versão completa - Campus Neurológico Sénior

CurriculumVitae
JoaquimJoséCoutinhoFerreira
LaboratóriodeFarmacologiaClínicaeTerapêutica
FaculdadedeMedicina
UniversidadedeLisboa
Av.Prof.EgasMoniz
Localedatadenascimento:
1649-028Lisboa
TorresVedras,30deNovembrode1968
Portugal
Casado,6filhos
[email protected]
Nacionalidade:Portuguesa
Cargosatuais
2015-
Presidente,SecçãoEuropeiadaInternacionalParkinsonandMovement
DisorderSociety(MDS)
2013-
DiretorClínico,CNSCampusNeurológicoSénior,TorresVedras
2013-
GrouLeader,UnidadedeFarmacologiaClínica(JoaquimFerreiraLab),Institutode
MedicinaMolecular(IMM)
DiretordoLaboratóriodeFarmacologiaClínicaeTerapêutica,Faculdadede
Medicina,UniversidadedeLisboa(FMUL)
2011-
2010-
ProfessorAssociadoConvidadodeFarmacologiaClínicaeNeurologia,FMUL
2003-
AssistenteHospitalardeNeurologia,HospitaldeSantaMaria,CentroHospitalar
LisboaNorte
Educação
2015
ConsultordeNeurologiadaCarreiraMédicaHospitalarpelaOrdemdosMédicos
2009
DoutoramentoemMedicina(Neurologia)pelaFMUL(“Anti-Parkinsoniandrugsand
sleepdisordersinParkinson’sDisease”);orientadores:Prof.DoutoraCristina
SampaioeProf.DoutorOlivierRascol(aprovadocomdistinçãoelouvor)
EspecialistaemFarmacologiaClínicapelaOrdemdosMédicos
2008
2001
EspecialistaemNeurologiapeloHospitaldeSantaMaria(HSM),comaclassificação
finalde19,7valores
1999-2000
EstágiodeFarmacologiaClínica,DepartamentodeFarmacologiaClínicae
Neurociências,UniversidadePaulSabatier,Toulouse,França(Orientador:Prof.
DoutorOlivierRascol)
LicenciaturaemMedicinapelaFMUL(1992),comamédiafinalde17valores(bom
comdistinção)
AdmissãonoCursodeMedicinadaFMUL,comamédiadecandidaturade19,8
valores
12ºanonaEscolaSecundárian.º2deTorresVedras,comamédiafinalde20valores
1992
1986
1986
Cargoseatividadesacadémicas
2012-
2011-
ProfessorAssociadoConvidadodeFarmacologiaClínicaeNeurologiadaFMULa
100%
RegentedasDisciplinasdeFarmacologiaClínicadaFMUL
2011-
DiretordoLaboratóriodeFarmacologiaClínicaeTerapêutica,FMUL
2009–2012
ProfessorAuxiliarConvidadodeFarmacologiaClínicaeNeurologiadaFMULa30%
2009-
ResponsávelpelomóduloTherapeuticResearchinNeurosciencesdoProgramade
Mestrado/DoutoramentoemNeurociênciasdaFMUL
DocenteconvidadodomódulodeDoençasNeurodegenerativasdoPrograma
DoutoralparaMédicosdaGulbenkian
DocenteconvidadodaCadeiradeNeurologiadaLicenciaturaemNutrição,FMUL
2009–2011
2008–2009
2001–2009
2000-2001
AssistentedeTerapêuticaGeraleNeurologiadaFMULcomduplatitulação(afectoà
CadeiradeTerapêuticaGeral)
DocenteconvidadodacadeiradeFormaçãoComplementar(6ºano),FMUL
1998–2009
DocenteconvidadodosMestradosdeNeurociências,MedicinadoSono,Educação
MédicaeCuidadosPaliativosdaFMUL
ResponsávelpelacadeiradeNeurologiadoCursoSuperiordeTerapêuticadaFala
(EscolaSuperiordeSaúdedeAlcoitão)
ResponsávelpelacadeiradeNeurofisiologiadoCursoSuperiordeTerapêutica
Ocupacional(EscolaSuperiordeSaúdedeAlcoitão)
AssistenteconvidadodeTerapêuticaGeral,FMUL
1995–1998
AssistenteLivredeTerapêuticaGeral,FMUL
1988–1990
MonitordeAnatomiaII,FMUL
2000-
1997–2001
1996–1997
Atividadeassistencial
2013-
DiretorClínico,CNSCampusNeurológicoSénior,TorresVedras
2003-
AssistenteHospitalardeNeurologia,ServiçodeNeurologia,HospitaldeSantaMaria
(HSM),Lisboa
Assistente Hospitalar de Neurologia, Serviço de Neurologia, Hospital Rainha Santa
Isabel,TorresNovas
Assistente Eventual de Neurologia, Serviço de Neurologia, Hospital de São José,
Lisboa
AssistenteEventualdeNeurologia,ServiçodeNeurologia,HSM
2002–2003
2001-2002
2001
1998–2011
Coordenadordostratamentoscomtoxinabotulínica,ServiçodeNeurologia,HSM
1995–2001
InternodoInternatoComplementardeNeurologia,ServiçodeNeurologia,HSM
1993–1994
InternodoInternatoGeral,HSM
1991-
MembrodoGrupodeDoençasdoMovimento,ServiçodeNeurologia,HSM
Atividadedeinvestigação
2013-
2009-
2002-2009
1999–2000
1992-2002
GrouLeader,UnidadedeFarmacologiaClínica(JoaquimFerreiraLab),IMM
InvestigadorPrincipal,UnidadeNeurológicadeInvestigaçãoClínica,IMM
Investigador,UnidadeNeurológicadeInvestigaçãoClínica,IMM
Estagiário, Laboratório de Farmacologia Médica e Clínica e Centro de Investigação
Clínica,Toulouse,França
Investigador,CentrodeNeurociênciasdeLisboa
CargosemSociedadesCientíficasNacionais
2012–2015
2012-
2012-
PresidentedaSociedadePortuguesadeDoençasdoMovimento
RepresentantedaSociedadePortuguesadeNeurologia(SPN)noEuropeanBoardof
NeurologicalofEuropeanUnionofMedicalSpecialists(UEMS/EBN)
MembrodoColégiodeFarmacologiaClínicadaOrdemdosMédicos
2008–2010
ResponsávelpeloGrupodeTrabalhodaSPNsobreCreditação
2006–2008
Vice-presidentedaSecçãodeDoençasdoMovimentodaSPN
2005–2007
MembrodaComissãodeEnsinodaSPN
2001–2005
SecretáriodaSecçãodeDoençasdoMovimentodaSPN
2000–2005
AssessordaComissãodeJovensdaSociedadePortuguesadeNeurologia(SPN)
CargosemSociedadesCientíficasInternacionais
2015-
MembrodoComitéExecutivodaEuropeanAcademyofNeurology(EAN)
2015-
Presidente,SecçãoEuropeiadaInternationalParkinsonandMovement
DisorderSociety(MDS)
2014-
2013–2015
ResponsáveldaTaskForcederevisãoterapêuticadaDoençadeHuntingtondaMDS
Presidente-eleito,SecçãoEuropeiadaMDS
2012–2015
ResponsávelpeloComitédeEducaçãodaMDS
2011–2013
CorresponsávelpeloComitédeMembroseRelaçõesPúblicasdaMDS
2011-
2008–2012
MembrodaTasqueForcedetremor(responsáveldoworkinggroupderevisão
terapêutica)daMDS
2008–2011
ResponsávelpeloSub-comitédeEducaçãodaSecçãoEuropeiadaMDS
MembrodoWebSiteEditorialBoarddaMDS
2007–2011
MembrodoComitéExecutivodaSecçãoEuropeiadaMDS
2007–2008
MembrodoGrupodeTrabalhoda“Website”daMDS
2004–2006
MembrodoComitédeRelaçõesPúblicaseLigaçãodaMDS
2003–
2000-2003
1999-2001
1998–2001.
MembrodoComitédeEducaçãodaMDS
SecretáriodopaineldeNeurofarmacologiadaEuropeanFederationofNeurological
Societies(EFNS)
Vice-presidente da European Association for Young Neurologists and Neurology
Trainees(YNT)
MembrodoSteeringCommitteeofTraineesandJuniorNeurologistsdaEFNS
OutrasatividadesemInstituições/OrganizaçõesNacionais
2008-
2000-
1997-2002
MembrodoComitéCientíficodaAssociaçãoPortuguesadeDoentesdeParkinson
ConsultordaUnidadedeFarmacovigilânciadeLisboaeValedoTejo,FMUL
MembrodoCentrodeMedicinaBaseadanaEvidencia,FMUL
OutrasatividadesemInstituições/OrganizaçõesInternacionais
2011-
CorresponsáveldoClinicalWorkingPartie,COSTActionBM1101Europeannetwork
forthestudyofdystoniasyndromes
2011-
MembrodoClinicalTrialsTaskforce,EuropeanHuntingtonDiseaseNetwork(EHDN)
2010-2012
DiretorCientífico,EuropeiaHuntingtonDiseaseNetwork(EHDN)
2008–2014
ResponsáveldoTheNeuroprotecticeTherapyWorkingGroup,EHDN
2008–
2006–2010
MembrodoComitéExecutivodaEHDN
MembrodoScientificandBioethicsAdvisoryCommitteedaEHDN
Atividadesdedireção/coordenação
2013-
Presidente,SecçãoEuropeiadaInternationalParkinsonandMovement
DisorderSociety(MDS)
DiretorClínico,CNSCampusNeurológicoSénior,TorresVedras
2013-
GroupLeader,InstitutodeMedicinaMolecular
2015-
2012–2015
PresidentedaSociedadePortuguesadeDoençasdoMovimento
2011-
RegentedasDisciplinasdeFarmacologiaClínicadaFMUL
2011-
DiretordoLaboratóriodeFarmacologiaClínicaeTerapêutica,FMUL
2010-2012
DiretorCientífico,EuropeanHuntingtonDiseaseNetwork
2009–2011
ResponsávelpeloComitédeRelaçõesPúblicaseLigaçãodaMDS
2008–2012
ResponsávelpeloSubcomitédeEducaçãodaSecçãoEuropeiadaMDS
CoordenadordaUnidadedeEnsaiosClínicosdoServiçodeNeurologia,HSM,CHLN
2000-
1996–2011
CoordenadordoCochraneMovimenteDisordersReviewGroupdaCochrane
Collaboration
Projetosdeinvestigaçãofinanciados
2014-
2014-
2013-
2013-
ProjetofinanciadopelaJPND:COURAGE-PDCOmprehensive
UnbiasedRiskFactorAssessmentforGeneticsand
EnvironmentinParkinson’sDisease(IMM€130.000)
ProjetofinanciadopelaJPND:Clãs:CareforLateStage
Parkinsonism(IMM€110.000)
ProjetofinanciadopelaFCT:ImaginaofBasalGangliafrom
MagneticInductionTomography
ProjetofinanciadopelaFCT:GlucocerebrosidaseinParkinson's
disease:fromriskfactortobiomarker
Investigador
ResponsávelWP
Systematicreview
Investigador
Investigador
2012–2014 ProjetofinanciadopelaFP7:SENSE-PARK(2012-2015):Sporting Responsávelpelowork
andEmpoweringParkinsonpatientsintheirhomeenvironment package7:scenario-based
usingaNovelSensoryinformationsystemthatmonitorsdaily
multicenterstudy
life-relevantparametersofParkinsondiseaseandtheirchange.
(IMM€214.880,00)
2010–2014 ProjetofinanciadopelaAPDPeDRS:Epidemiológicastudyto
assesstheprevalenceofParkinson'sdiseaseinPortugal,
€150.000,00
Investigadorprincipal
2008-2011
ProjetofinanciadopelaFCT:ShowandRapidProgression
Parkinson´sDisease:MolecularDeterminantsandBiomarkers,
FoundationforScienceandTechnology.Investigadorprincipal:
TiagoOuteiro.PIC/IC/82760/2007,€195.000,00
Investigador
2006-2008
ProjetofinanciadopelaFCT:MicroRnómicaandproteomicsof
Investigador
Parkinson'sdisease."Studyconductedincollaborationwiththe
GulbenkianInstituteofScience.PTDC/SAU-GMG/64428/2006,
€121.960,00
Atividadeeditorial/revisor
EditorassociadodosjornaisFronteirasinMovementDisorderseActaReumatológicaPortuguesa(20052007)
MembrodoComitéEditorialdosjornais:JournalofParkinson’sDisease,JournalofHuntington’sDisease,
PLOSCurrentsHuntingtonDisease
Revisorconvidadodosjornais:CNSNeuroscienceandTherapeutics,EuropeanJournalofNeurology,
MovementDisordersJournal,ExpertReviewofNeurotherapeutics,ExpertOpiniononDrugSafety,Aging
Health,TheJournalofPain,JournalofNeurology,NeuroscienceLetters,Sinapse,JournalofNeurology
NeurosurgeryandPsychiatry,JournalofMedicalEthics,JournalofNeuralTransmission,TheEuropean
NeurologicalJournal,Dovepress,ExpertOpinionOnDrugMetabolismandToxicology,Parkinsonismand
RelatedDisorders
RevisorconvidadodecandidaturasparafinanciamentosubmetidasaoParkinson’sDiseaseSociety,UK
(2009-2010);ActionMedicalResearch,UK(2007);GabinetedeApoioàInvestigaçãoCientífica(GAPIC),
FMUL
Revisor convidado do2012NEURONjointtransnationalcall“NovelMethodsandApproachestowardsthe
UnderstandingofBrainDiseases”
Orientaçãodeformaçãoetesesdemestrado/doutoramento
Orientadordeformaçãode3internosdeneurologia(2concluídos)
Orientadorde10tesesdoMestradoIntegradoemMedicinadaFMUL
Orientadorde2dissertaçõesdemestradoemneurociênciasapresentadasàFMULe3emcurso
Orientadorde2dissertaçõesdemestradoapresentadasàUniversidadeCatólicaPortuguesa
OrientadordeumatesededoutoramentoapresentadaàFMUL(concluída)eseisdissertaçõesemcursona
FMUL
Áreasdeinteressepreferencial
FarmacologiaClínica,Neurofarmaclogia,DoençasdoMovimento,DoençadeParkinson,Doençade
Huntington,ToxinaBotulínica,EnsaiosClínicos,RevisõesSistemáticas
Publicaçõesemrevistasindexadas(h-índex38;nºcitações5332)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
RuiAraújo,JoaquimJFerreira,AngeloAntonini,BastiaanRBloem:"Gunslinger'sgait":anewcauseofunilaterallyreducedarmswing.BMJ(online)
12/2015;351:h6141.DOI:10.1136/bmj.h6141
JoaquimJFerreira,AndrewLees,José-FranciscoRocha,WernerPoewe,OlivierRascol,PatrícioSoares-da-Silva:Opicaponeasanadjuncttolevodopa
inpatientswithParkinson'sdiseaseandend-of-dosemotorfluctuations:arandomised,double-blind,controlledtrial.TheLancetNeurology12/2015;
DOI:10.1016/S1474-4422(15)00336-1
MargheritaFabbri,MarioMRosa,DaisyAbreu,JoaquimJFerreira:ClinicalpharmacologyreviewofsafinamideforthetreatmentofParkinson’s
disease.11/2015;5(6).DOI:10.2217/nmt.15.46
SReimão,SFerreira,RGNunes,PPitaLobo,DNeutel,DAbreu,NGonçalves,JCampos,JJFerreira:Magneticresonancecorrelationofironcontent
withneuromelanininthesubstantianigraofearly-stageParkinson'sdisease.EuropeanJournalofNeurology10/2015;DOI:10.1111/ene.12838
TiagoTeodoro,PedroViana,DaisyAbreu,IsabelConceição,RitaPeralta,JoaquimJFerreira:Aperipheralpathwaytorestlesslegssyndrome?Clues
fromfamilialamyloidpolyneuropathy.Parkinsonism&RelatedDisorders10/2015;21.DOI:10.1016/j.parkreldis.2015.10.012
MargheritaFabbri,GiorgioLeodori,RicardoMFernandes,RoongrojBhidayasiri,MariaJoseMarti,CarloColosimo,JoaquimJFerreira:Neutralizing
AntibodyandBotulinumToxinTherapy:ASystematicReviewandMeta-analysis.NeurotoxicityResearch10/2015;DOI:10.1007/s12640-015-9565-5
DulceNeutel,RitaPeralta,JoanaPires,CarlaBentes,JoaquimJ.Ferreira:EndofOSLERTestSessionsinParkinson’sDiseasedonotCorrespondtoTrue
SleepOnset:ResultsfromanExploratoryStudy.FrontiersinNeurology09/2015;6.DOI:10.3389/fneur.2015.00200
JosefaMDomingos,CatarinaGodinho,JohnDean,MiguelCoelhoMd,AnabelaPinto,BastiaanRBloem,JoaquimJFerreira:CognitiveImpairmentin
Fall-RelatedStudiesinParkinsonDisease.JournalofParkinson'sDisease09/2015;5(3):453-469.DOI:10.3233/JPD-150590
SofiaReimão,PatriciaPitaLobo,DulceNeutel,LeonorCorreiaGuedes,MiguelCoelho,MarioM.Rosa,JoanaFerreira,DaisyAbreu,NilzaGonçalves,
CarlosMorgado,RitaG.Nunes,JorgeCampos,JoaquimJ.Ferreira:QuantitativeAnalysisVersusVisualAssessmentofNeuromelaninMRImagingfor
theDiagnosisofParkinson’sdisease.JournalofParkinson'sDisease09/2015;5(3):561-567.DOI:10.3233/JPD-150551
DanielCaldeira,JoaquimJFerreira,JoãoCosta:GlaucomaSurgeryandAnticoagulantTherapy-Reply.JamaOphthalmology09/2015;
DOI:10.1001/jamaophthalmol.2015.3073
D.Caldeira,M.Barra,A.Ferreira,A.Rocha,A.Augusto,F.J.Pinto,J.Costa,J.J.Ferreira:Systematicreviewwithmeta-analysis:Theriskofmajor
gastrointestinalbleedingwithnon-VitaminKantagonistoralanticoagulants.AlimentaryPharmacology&Therapeutics09/2015;42(11):n/a-n/a.
DOI:10.1111/apt.13412
OlivierRascol,SantiagoPerez-Lloret,JoaquimJFerreira:Newtreatmentsforlevodopa-inducedmotorcomplications.MovementDisorders08/2015;
30(11).DOI:10.1002/mds.26362
José-FranciscoRocha,JoaquimJ.Ferreira,AmílcarFalcão,AnaSantos,RobertoPinto,TeresaNunes,LuisAlmeida,PatrícioSoares-da-Silva:Effectof
threesingle-doseregimensofopicaponeonlevodopapharmacokinetics,catechol-O-methyltransferaseactivityandmotorresponseinpatientswith
Parkinson'sdisease.ClinicalPharmacologyinDrugDevelopment08/2015;DOI:10.1002/cpdd.217
JoaquimJFerreira,AnneRosser,DavidCraufurd,FerdinandoSquitieri,NicholasMallard,BernhardLandwehrmeyer:Ethyl-eicosapentaenoicacid
treatmentinHuntington'sdisease:Aplacebo-controlledclinicaltrial.MovementDisorders07/2015;30(10).DOI:10.1002/mds.26308
DanielCaldeira,NilzaGonçalves,JoaquimJFerreira,FaustoJPinto,JoãoCosta:TolerabilityandAcceptabilityofNon-VitaminKAntagonistOral
AnticoagulantsinAtrialFibrillation:SystematicReviewandMeta-Analysis.AmericanJournalofCardiovascularDrugs06/2015;15(4).
DOI:10.1007/s40256-015-0132-5
JoaquimJ.Ferreira,CatarinaGodinho,AnaT.Santos,JosefaDomingos,DaisyAbreu,RaquelLobo,NilzaGonçalves,MarcioBarra,FrankLarsen,
ØyvindFagerbakke,IngvildAkeren,HildeWangen,J.ArturSerrano,PeterWeber,AndreaThoms,StefanMeckler,StefanSollinger,JanetvanUem,
MarkusA.Hobert,KatrinS.Maier,HelenMatthew,TomIsaacs,JoyDuffen,HolmGraessner,WalterMaetzler:Quantitativehome-basedassessment
ofParkinson’ssymptoms:TheSENSE-PARKfeasibilityandusabilitystudy.BMCNeurology06/2015;15(1).DOI:10.1186/s12883-015-0343-z
InêsTelloRodrigues,JoaquimJFerreira,MiguelCoelho,MarioMiguelRosa,AlexandreCastro-Caldas:ActionverbalfluencyinParkinson’spatients.
ArquivosdeNeuro-Psiquiatria06/2015;73(6).DOI:10.1590/0004-282X20150056
DanielCaldeira,FilipeBRodrigues,MárcioBarra,AnaTeresaSantos,DaisydeAbreu,NilzaGonçalves,FaustoJPinto,JoaquimJFerreira,JoãoCosta:
Non-VitaminKantagonistoralanticoagulantsandmajorbleeding-relatedfatalityinpatientswithatrialfibrillationandvenousthromboembolism:A
systematicreviewandmeta-analysis.Heart(BritishCardiacSociety)06/2015;101(15):1204-11.DOI:10.1136/heartjnl-2015-307489
TiagoTeodoro,HipólitoNzwalo,LeonorCorreiaGuedes,MiguelCoelho,MárioM.Rosa,JoaquimJ.Ferreira:Suicidalbehaviorsareveryrarein
antiparkinsoniandrugtrials.Parkinsonism&RelatedDisorders06/2015;21(8).DOI:10.1016/j.parkreldis.2015.06.011
DanielCaldeira,MárioCanastro,MárcioBarra,AdrianaFerreira,JoãoCosta,FaustoJPinto,JoaquimJFerreira:RiskofSubstantialIntraocularBleeding
WithNovelOralAnticoagulants.JamaOphthalmology05/2015;133(7).DOI:10.1001/jamaophthalmol.2015.0985
TiagoTeodoro,PatríciaPitaLobo,JoãoFerreira,RitaSousa,SofiaReimão,RitaPeralta,LuísaAlbuquerque,JoaquimJ.Ferreira:DelayedParkinsonism
afteracutechoreaduetonon-ketotichyperglycemia.Journaloftheneurologicalsciences05/2015;354(1-2).DOI:10.1016/j.jns.2015.04.039
JoanaMorgado,SofiaReimão,MiguelCoelho,MárioM.Rosa,JoaquimJ.Ferreira,LeonorCorreiaGuedes:EyeoftheTigerSignandVeryLateOnsetin
Dentatorubral-PallidoluysianAtrophy.05/2015;2(3).DOI:10.1002/mdc3.12179
DanielCaldeira,NilzaGonçalves,FaustoJ.Pinto,JoãoCosta,JoaquimJ.Ferreira:Riskofrenalfailurewiththenon-vitaminKantagonistoral
anticoagulants:systematicreviewandmeta-analysis:NOACsandIncidenceofRenalFailure.PharmacoepidemiologyandDrugSafety05/2015;24(7).
DOI:10.1002/pds.3791
24. SofiaReimão,PatriciaPitaLobo,DulceNeutel,LeonorCorreiaGuedes,MiguelCoelho,MárioMRosa,PedroAzevedo,JoanaFerreira,DaisyAbreu,
NilzaGonçalves,RitaGNunes,JorgeCampos,JoaquimJFerreira:Substantianigraneuromelanin-MRimagingdifferentiatesessentialtremorfrom
Parkinson'sdisease.MovementDisorders03/2015;30(7).DOI:10.1002/mds.26182
25. JoaquimJFerreira,AnaTSantos,JosefaDomingos,HelenMatthews,TomIsaacs,JoyDuffen,AhmedAl-Jawad,FrankLarsen,ArturSerrano,Peter
Weber,AndreaThoms,StefanSollinger,HolmGraessner,WalterMaetzler:ClinicalParametersandToolsforHome-BasedAssessmentofParkinson’s
Disease:ResultsfromaDelphistudy.JournalofParkinson'sDisease02/2015;5(2).DOI:10.3233/JPD-140493
26. DanielCaldeira,JoãoCosta,JoaquimJFerreira,GregoryYHLip,FaustoJPinto:Non-vitaminKantagonistoralanticoagulantsinthecardioversionof
patientswithatrialfibrillation:systematicreviewandmeta-analysis.ClinicalResearchinCardiology02/2015;104(7).DOI:10.1007/s00392-015-08218
27. JoaquimJ.Ferreira,José-FranciscoRocha,AmílcarFalcão,AnaSantos,RobertoPinto,TeresaNunes,PatrícioSoares-da-Silva:Effectofopicaponeon
levodopapharmacokinetics,catechol-O-methyltransferaseactivityandmotorfluctuationsinpatientswithParkinson'sdisease.EuropeanJournalof
Neurology02/2015;22(5).DOI:10.1111/ene.12666
28. DanielCaldeira,MárcioBarra,AnaTeresaSantos,DaisydeAbreu,JoãoCosta,JoaquimJFerreira:Riskofinsomniawithnon-vitaminKoral
anticoagulants:systematicreviewandmeta-analysis.SleepAndBreathing01/2015;19(3).DOI:10.1007/s11325-014-1112-8
29. JArturSerrano,FrankLarsen,TomIsaacs,HelenMatthews,JoyDuffen,SaraRiggare,FulvioCapitanio,JoaquimJ.Ferreira,JosefaDomingos,Walter
Maetzler,HolmGraessner:ParticipatoryDesigninParkinson'sResearchwithFocusontheSymptomaticDomainstobeMeasured.Journalof
Parkinson'sDisease01/2015;5(1).DOI:10.3233/JPD-140472
30. DanielCaldeira,MárcioBarra,NilzaGonçalves,FaustoJPinto,JoaquimJFerreira,JoãoCosta:Pericardialbleedingriskwithnon-vitaminKoral
anticoagulants:Ameta-analysis.InternationalJournalofCardiology12/2014;182C:187-188.DOI:10.1016/j.ijcard.2014.12.062
31. S.Reimão,P.PitaLobo,D.Neutel,L.CorreiaGuedes,M.Coelho,M.M.Rosa,J.Ferreira,D.Abreu,N.Gonçalves,C.Morgado,R.G.Nunes,J.Campos,
J.J.Ferreira:SubstantianigraneuromelaninmagneticresonanceimagingindenovoParkinson'sdiseasepatients.EuropeanJournalofNeurology
12/2014;22(3).DOI:10.1111/ene.12613
32. JoaquimJ.Ferreira,CarloColosimo,RoongrojBhidayasiri,MariaJoseMarti,PascalMaisonobe,OmSavary:FactorsinfluencingsecondarynonresponsetobotulinumtoxintypeAinjectionsincervicaldystonia.Parkinsonism&RelatedDisorders11/2014;21(2).
DOI:10.1016/j.parkreldis.2014.09.034
33. DanielCaldeira,JoãoCosta,JoaquimJ.Ferreira,FaustoJ.Pinto:Thromboembolicriskintheinitiation,switchandinterruption/re-initiationoforal
anticoagulants:Donewcomersimproveoutcomes?Insightsfromameta-analysisofRCTs.InternationalJournalofCardiology11/2014;177(1):117–
119.DOI:10.1016/j.ijcard.2014.09.099
34. DanielCaldeira,JoãoCosta,MárcioBarra,FaustoJ.Pinto,JoaquimJ.Ferreira:HowsafeisacetaminophenuseinpatientstreatedwithvitaminK
antagonists?Asystematicreviewandmeta-analysis.ThrombosisResearch10/2014;135(1).DOI:10.1016/j.thromres.2014.10.011
35. MarialuisaQuadri,XuYang,GiovanniCossu,SimoneOlgiati,ValeriaMSaddi,GuidoJBreedveld,LimeiOuyang,JingchuHu,NaXu,JosjaGraafland,
ValeriaRicchi,DanielaMurgia,LeonorCorreiaGuedes,ClaudioMariani,MariaJMarti,PatriziaTarantino,RosannaAsselta,FrancescValldeoriola,
MonicaGagliardi,GianniPezzoli,MarioEzquerra,AldoQuattrone,JoaquimFerreira,GraziaAnnesi,StefanoGoldwurm,EduardoTolosa,BenAOostra,
MaurizioMelis,JunWang,VincenzoBonifati:AnexomestudyofParkinson’sdiseaseinSardinia,aMediterraneangeneticisolate.Neurogenetics
10/2014;16(1).DOI:10.1007/s10048-014-0425-x
36. DanielCaldeira,MárcioBarra,CláudioDavid,JoãoCosta,JoaquimJFerreira,FaustoJPinto:Theprevalenceoforalanticoagulationinpatientswith
atrialfibrillationinPortugal:Systematicreviewandmeta-analysisofobservationalstudies.09/2014;33(9).DOI:10.1016/j.repce.2014.02.011
37. MarcusMunafò,SimonNoble,WilliamJBrowne,DaniBrunner,KatherineButton,JoaquimFerreira,PeterHolmans,DouglasLangbehn,GlynLewis,
MartinLindquist,KateTilling,Eric-JanWagenmakers,RobiBlumenstein:Scientificrigorandtheartofmotorcyclemaintenance.NatureBiotechnology
09/2014;32(9):871-873.DOI:10.1038/nbt.3004
38. N.Goncalves,J.J.Ferreira,D.deAbreu,L.Correia-Guedes,J.Giuliano,C.Fitzer-Attas,C.Sampaio:J23EvaluationofValidityofUHDRSTranslationsin
theRegistryStudy.JournalofNeurologyNeurosurgery&Psychiatry09/2014;85(Suppl1):A73-A73.DOI:10.1136/jnnp-2014-309032.206
39. DanielCaldeira,MárcioBarra,CláudioDavid,JoãoCosta,JoaquimJ.Ferreira,FaustoJ.Pinto:Prevalênciadaanticoagulaçãooralemdoentescom
fibrilhaçãoauricularemPortugal:revisãosistemáticaemeta-análisedeestudosobservacionais.Revistaportuguesadecardiologia:orgaooficialda
SociedadePortuguesadeCardiologia=Portuguesejournalofcardiology:anofficialjournalofthePortugueseSocietyofCardiology09/2014;33(9).
DOI:10.1016/j.repc.2014.02.014
40. M.Coelho,M.J.Marti,C.Sampaio,J.J.Ferreira,F.Valldeoriola,M.M.Rosa,E.Tolosa:Dementiaandseverityofparkinsonismdeterminesthe
handicapofpatientsinlate-stageParkinson'sdisease:TheBarcelona-Lisboncohort.EuropeanJournalofNeurology09/2014;22(2).
DOI:10.1111/ene.12567
41. DanielCaldeira,MárcioBarra,FaustoJPinto,JoaquimJFerreira,JoãoCosta:Intracranialhemorrhageriskwiththeneworalanticoagulants:A
systematicreviewandmeta-analysis.JournalofNeurology08/2014;262(3).DOI:10.1007/s00415-014-7462-0
42. DanielCaldeira,MariaJoséLoureiro,JoãoCosta,FaustoJ.Pinto,JoaquimJ.Ferreira:OralAnticoagulationforPulmonaryArterialHypertension:
SystematicReviewandMeta-analysis.TheCanadianjournalofcardiology08/2014;30(8).DOI:10.1016/j.cjca.2014.04.016
43. WalterMaetzler,MarieKaram,MonikaFruhmannBerger,TanjaHeger,CorinaMaetzler,HeinzRuediger,JulianaBronzova,PatriciaPitaLobo,
JoaquimJFerreira,TjalfZiemssen,DanielaBerg:Time-andfrequency-domainparametersofheartratevariabilityandsympatheticskinresponsein
Parkinson’sdisease.JournalofNeuralTransmission07/2014;122(3).DOI:10.1007/s00702-014-1276-1
44. DanielCaldeira,JoãoCosta,RicardoMFernandes,FaustoJPinto,JoaquimJFerreira:PerformanceoftheHAS-BLEDhighbleeding-riskcategory,
comparedtoATRIAandHEMORR2HAGESinpatientswithatrialfibrillation:asystematicreviewandmeta-analysis.JournalofInterventionalCardiac
Electrophysiology07/2014;DOI:10.1007/s10840-014-9930-y
45. TiagoA.Mestre,TiagoTeodoro,WilliamReginold,JuliaGraf,MaikeKasten,JoannaSale,MateuszZurowski,JanisMiyasaki,JoaquimJ.Ferreira,
ConnieMarras:ReluctancetostartmedicationforParkinson’sdisease:Amutualmisunderstandingbypatientsandphysicians.Parkinsonism&
RelatedDisorders06/2014;20(6).DOI:10.1016/j.parkreldis.2014.03.001
46. DanielCaldeira,JoãoCosta,JoaquimJFerreira,FaustoJPinto:Netclinicalbenefitoutcomeshouldbestandardizedintrialsevaluatingantithrombotic
drugs:TheexampleofNOACsinatrialfibrillation.Internationaljournalofcardiology04/2014;174(2).DOI:10.1016/j.ijcard.2014.04.051
47. DanielCaldeira,FaustoJPinto,JoaquimJFerreira:DyspneaandReversibilityProfileofP2Y12Antagonists:SystematicReviewofNewAntiplatelet
Drugs.AmericanJournalofCardiovascularDrugs03/2014;14(4).DOI:10.1007/s40256-014-0071-6
48. M.Fabbri,L.C.Guedes,M.Coelho,D.Simão,D.Abreu,M.M.Rosa,L.Silveira-Moriyama,J.J.Ferreira:Subthalamicdeepbrainstimulationeffectson
odoridentificationinParkinson'sdisease.EuropeanJournalofNeurology03/2014;22(1).DOI:10.1111/ene.12396
49. DanielCaldeira,CláudioDavid,AnaT.Santos,JoãoCosta,FaustoJ.Pinto,JoaquimJ.Ferreira:Efficacyandsafetyoflowmolecularweightheparinin
patientswithmechanicalheartvalves:Systematicreviewandmeta-analysis.JournalofThrombosisandHaemostasis03/2014;12(5).
DOI:10.1111/jth.12544
50. DanielCaldeira,MárcioBarra,AnaTeresaSantos,DaisydeAbreu,FaustoJPinto,JoaquimJFerreira,JoãoCosta:Riskofdrug-inducedliverinjurywith
theneworalanticoagulants:Systematicreviewandmeta-analysis.Heart(BritishCardiacSociety)01/2014;100(7).DOI:10.1136/heartjnl-2013305288
51. DanielCaldeira,JoãoCosta,FaustoJPinto,JoaquimJFerreira:Theriskofinfectionwithneworalanticoagulants:Ameta-analysis.International
journalofcardiology01/2014;172(1).DOI:10.1016/j.ijcard.2013.12.248
52. JosefaDomingos,MiguelCoelho,JoaquimJFerreira:Referraltorehabilitationinparkinson'Sdisease:Who,whenandtowhatend?.Arquivosde
neuro-psiquiatria12/2013;71(12):967-972.DOI:10.1590/0004-282X20130209
53. LuisaAlbuquerque,MiguelCoelho,MaurícioMartins,LeonorCorreiaGuedes,MárioMRosa,JoaquimJFerreira,MariaBegoñaCattoni,Herculano
Carvalho,AGonçalvesFerreira,IsabelPavãoMartins:STN-DBSdoesnotchangeemotionrecognitioninadvancedParkinson'sdisease.Parkinsonism&
RelatedDisorders10/2013;20(2).DOI:10.1016/j.parkreldis.2013.10.010
54. J.J.Ferreira,J.-F.Rocha,A.Falcão,R.Pinto,T.Nunes,P.Soares-da-Silva:Effectofopicaponemultiple-doseregimensonlevodopapharmacokinetics,
motorresponse,anderythrocyte-COMTactivityinParkinson'spatientsco-administeredwithlevodopa/dopa-decarboxylaseinhibitor.
55. WalterMaetzler,JosefaDomingos,KarinSrulijes,JoaquimJFerreira,BastiaanRBloem:QuantitativeWearableSensorsforObjectiveAssessmentof
Parkinson'sDisease.MovementDisorders10/2013;28(12).DOI:10.1002/mds.25628
56. DanielCaldeira,CristinaMartins,LuísBrandãoAlves,HélderPereira,JoaquimJFerreira,JoãoCosta:Caffeinedoesnotincreasetheriskofatrial
fibrillation:Asystematicreviewandmeta-analysisofobservationalstudies.Heart(BritishCardiacSociety)10/2013;99(19):1383-9.
DOI:10.1136/heartjnl-2013-303950
57. JörgWissel,JoaquimJ.Ferreira,DjamelBensmail,PeterKossmehl,LourdesLópezdeMunaín,TiinaRekand,LalithSatkunam,DavidSimpson:TOWER:
DesignofanOpen-LabelIncobotulinumtoxinaDose-TitrationStudy(≤800U)InLower-andUpper-LimbSpasticity.PM&R09/2013;5(9):S142-S143.
DOI:10.1016/j.pmrj.2013.08.039
58. PatriciaPitaLobo,MiguelCoelho,TiagoAMestre,MárioMRosa,JoaquimJFerreira:Wearing-offphenomenaandlevodopa-induceddyskinesiasin
posttraumatichemiparkinsonism.MovementDisorders08/2013;28(9).DOI:10.1002/mds.25556
59. DanielCaldeira,RicardoMFernandes,CláudioDavid,JoãoCosta,JoaquimJFerreira:Warfarin,acetylsalicylicacidandriskofincidentatrialfibrillation
inpatientswithheartfailureandsinusrhythm:Ameta-analysis.Internationaljournalofcardiology07/2013;168(5).DOI:10.1016/j.ijcard.2013.07.033
60. S.Metzger,C.Walter,O.Riess,R.A.Roos,J.E.Nielsen,D.Craufurd,A.C.Bachoud-Lévi,A.R.Bentivoglio,I.Biunno,R.M.Bonelli,J.M.Burgunder,
S.B.Dunnett,J.J.Ferreira,O.J.Handley,etal:TheV471APolymorphisminautophagy-relatedgeneATG7modifiesageatonsetspecificallyin
ItalianHuntingtondiseasepatients.PLoSONE07/2013;
61. IsabelPavãoMartins,GabrielaLeal,IsabelFonseca,LuísaFarrajota,MartaAguiar,JoséFonseca,MartinLauterbach,LuísGonçalves,MCarmoCary,
JoaquimJFerreira,JoseMFerro:Arandomized,rater-blinded,paralleltrialofintensivespeechtherapyinsub-acutepost-strokeaphasia:TheSP-I-R-IT
study.InternationalJournalofLanguage&CommunicationDisorders07/2013;48(4):421-31.DOI:10.1111/1460-6984.12018
62. LeiZhang,MarialuisaQuadri,LeonorCorreiaGuedes,MiguelCoelho,AnabelaValadas,TiagoMestre,PatríciaPitaLobo,MárioMiguelRosa,Erik
Simons,BenAOostra,JoaquimJFerreira,VincenzoBonifati:ComprehensiveLRRK2andGBAscreeninginPortuguesepatientswithParkinson's
disease:IdentificationofanewfamilywiththeLRRK2p.Arg1441Hismutationandnovelmissensevariants.Parkinsonism&RelatedDisorders
05/2013;19(10).DOI:10.1016/j.parkreldis.2013.05.003
63. TiagoTeodoro,DulceNeutel,PatríciaLobo,AnaFGeraldo,IsabelConceição,MárioMRosa,LuísaAlbuquerque,JoaquimJFerreira:Recoveryafter
copper-deficiencymyeloneuropathyinWilson'sdisease.JournalofNeurology05/2013;260(7).DOI:10.1007/s00415-013-6963-6
64. W.Maetzler,M.Karam,T.Heger,P.PitaLobo,J.J.Ferreira,T.Ziemssen,D.Berg:HeartratevariabilityandsympatheticskinresponseinParkinson's
disease:BaselineassessmentoftheMODEPstudy.BasalGanglia03/2013;3(1):63–64.DOI:10.1016/j.baga.2013.01.064
65. ABerardelli,GKWenning,AAntonini,DBerg,BRBloem,VBonifati,DBrooks,DJBurn,CColosimo,AFanciulli,JFerreira,TGasser,FGrandas,P
Kanovsky,VKostic,JKulisevsky,WOertel,WPoewe,J-PReese,MRelja,ERuzicka,ASchrag,KSeppi,PTaba,MVidailhet:EFNS/MDS-ES/ENS
[corrected]recommendationsforthediagnosisofParkinson'sdisease.EuropeanJournalofNeurology01/2013;20(1):16-34.DOI:10.1111/ene.12022
66. JJFerreira,RKatzenschlager,BRBloem,UBonuccelli,DBurn,GDeuschl,EDietrichs,GFabbrini,AFriedman,PKanovsky,VKostic,ANieuwboer,P
Odin,WPoewe,ORascol,CSampaio,MSchüpbach,ETolosa,CTrenkwalder,ASchapira,ABerardelli,WHOertel:Summaryoftherecommendations
oftheEFNS/MDS-ESreviewontherapeuticmanagementofParkinson'sdisease.EuropeanJournalofNeurology01/2013;20(1):5-15.
DOI:10.1111/j.1468-1331.2012.03866.x
67. DanielCaldeira,RicardoMFernandes,JoãoCosta,CláudioDavid,CristinaSampaio,JoaquimJFerreira:BrandedVersusGenericClopidogrelin
CardiovascularDiseases:ASystematicReview.Journalofcardiovascularpharmacology11/2012;61(4).DOI:10.1097/FJC.0b013e31827e5c60
68. T.A.Mestre,A.E.Lang,J.J.Ferreira:Associatedmovementdisordersinorthostatictremor(vol83,pg725,2012).JournalofNeurologyNeurosurgery
&Psychiatry11/2012;83(11):1132-1132.DOI:10.1136/jnnp-2012-302436corr1
69. JoaquimJFerreira,DulceNeutel,TiagoAMestre,MoniqueGalitzky,ClaireThalamas,AnaTSantos,CristinaSampaio,OlivierRascol:Usefulnessof
OSLERtestinParkinson'sdisease.SleepMedicine10/2012;14(3).DOI:10.1016/j.sleep.2012.09.005
70. JoaquimJFerreira,RoongrojBhidayasiri,CarloColosimo,MariaJoseMarti,BenjaminZakine,PascalMaisonobe:Surveyofpracticesemployedby
neurologistsforthedefinitionandmanagementofsecondarynonresponsetobotulinumtoxinincervicaldystonia.Functionalneurology10/2012;
27(4):225-230.
71. RobertBChinnapongse,MarkFLew,JoaquimJFerreira,KristenLGullo,PaulRNemeth,YuxinZhang:ImmunogenicityandLong-TermEfficacyof
BotulinumToxinTypeBintheTreatmentofCervicalDystonia.Clinicalneuropharmacology08/2012;35(5):215-23.
DOI:10.1097/WNF.0b013e318263163c
72. MiguelCoelho,JoaquimJFerreira:Late-stageParkinsondisease.NatureReviewsNeurology07/2012;8(8):435-42.DOI:10.1038/nrneurol.2012.126
73. TiagoAMestre,AELang,JoaquimJFerreira,VâniaAlmeida,MamededeCarvalho,JanisMiyasaki,RobertChen,SusanFox:Associatedmovement
disordersinorthostatictremor.Journalofneurology,neurosurgery,andpsychiatry05/2012;83(7):725-9.DOI:10.1136/jnnp-2012-302436
74. SusanaMargaridaRodrigues,MamededeCarvalho,TiagoMestre,JoaquimJFerreira,MiguelCoelho,RitaPeralta,PauloVale:Paralyticshellfish
poisoningduetoingestionofGymnodiniumcatenatumcontaminatedcockles-ApplicationoftheAOACHPLCOfficialMethod.Toxicon04/2012;
59(5):558-66.DOI:10.1016/j.toxicon.2012.01.004
75. T.A.Mestre,J.J.Ferreira:Anevidence-basedapproachinthetreatmentofHuntington'sdisease.Parkinsonism&RelatedDisorders12/2011;
18(4):316-20.DOI:10.1016/j.parkreldis.2011.10.021
76. ChristopherGGoetz,GlennTStebbins,AdTheeuwes,FabrizioStocchi,JoaquimJFerreira,SergevandeWitte,JulianaBronzova:Temporalstabilityof
theUnifiedDyskinesiaRatingScale.MovementDisorders12/2011;26(14):2556-9.DOI:10.1002/mds.23931
77. MadalenaMartins,AlexandraRosa,LeonorCGuedes,BeneditaVFonseca,KristinaGotovac,SaraViolante,TiagoMestre,MiguelCoelho,MárioM
Rosa,EdenRMartin,JefferyMVance,TiagoFOuteiro,LiyongWang,FranBorovecki,JoaquimJFerreira,SofiaAOliveira:ConvergenceofmiRNA
ExpressionProfiling,α-SynucleinInteractonandGWASinParkinson'sDisease.PLoSONE10/2011;6(10):e25443.DOI:10.1371/journal.pone.0025443
78. TiagoTeodoro,DanielaPires,MárioMRosa,MiguelCoelho,CristinaSampaio,JoaquimJFerreira:Has"Levodopa-InducedNeuropathy"Been
ReportedinParkinson'sDiseaseClinicalTrials?.MovementDisorders08/2011;26(10):1966-7.DOI:10.1002/mds.23760
79. AnabelaValadas,MiguelCoelho,TiagoMestre,LeonorCorreiaGuedes,MariaFinisterra,AnaNoronha,MárioMRosa,CristinaSampaio,JoaquimJ
Ferreira:WhatmotivatesParkinson'sdiseasepatientstoenterclinicaltrials?.Parkinsonism&RelatedDisorders06/2011;17(9):667-71.
DOI:10.1016/j.parkreldis.2011.05.023
80. OlivierRascol,JoaquimFerreira,LaurenceNègre-Pages,SantiagoPerez-Lloret,LucetteLacomblez,MoniqueGalitzky,Jean-ChristopheLemarié,JeanChristopheCorvol,JonathanMBrotchie,LauraBossi:Aproof-of-concept,randomized,placebo-controlled,multiplecross-overs(n-of-1)studyof
naftazoneinParkinson'sdisease.FundamentalandClinicalPharmacology05/2011;26(4):557-64.DOI:10.1111/j.1472-8206.2011.00951.x
81. SReimão,CMorgado,LNeto,JFerreira,MCoelho,MRosa,JCampos:DiffusionTensorImaginginMovementDisorders:ReviewofMajorPatterns
andCorrelationwithNormalBrainstem/cerebellarWhiteMatter.05/2011;24(2):177-86.DOI:10.1177/197140091102400203
82. BirgitHögl,IsabelleArnulf,CynthiaComella,JoaquimFerreira,AlexIranzo,BarbaraTilley,ClaudiaTrenkwalder,WernerPoewe,OlivierRascol,Cristina
Sampaio,GlennTStebbins,AnetteSchrag,ChristopherGGoetz:ScalestoAssessSleepImpairmentinParkinson'sDisease:Critiqueand
Recommendations.MovementDisorders12/2010;25(16):2704-16.DOI:10.1002/mds.23190
83. JoaquimJFerreira,OlivierRascol,WernerPoewe,CristinaSampaio,José-FranciscoRocha,TeresaNunes,LuisAlmeida,PatrícioSoares-da-Silva:A
Double-Blind,Randomized,PlaceboandActive-ControlledStudyofNebicaponefortheTreatmentofMotorFluctuationsinParkinson'sDisease.CNS
Neuroscience&Therapeutics12/2010;16(6):337-47.DOI:10.1111/j.1755-5949.2010.00145.x
84. CristinaSampaio,JoaquimJFerreira:Parkinsondisease:Adjunctiveentacaponetherapyincreasesriskofdyskinesia.NatureReviewsNeurology
11/2010;6(11):590-1.DOI:10.1038/nrneurol.2010.158
85. W.H.Oertel,A.Berardelli,B.R.Bloem,U.Bonuccelli,D.Burn,G.Deuschl,E.Dietrichs,G.Fabbrini,J.J.Ferreira,A.Friedman,P.Kanovsky,V.Kostic,A.
Nieuwboer,P.Odin,W.Poewe,O.Rascol,C.Sampaio,M.Schüpbach,E.Tolosa,C.Trenkwalder:Early(Uncomplicated)Parkinson'sDisease.
86. M.Coelho,T.Mestre,J.J.Ferreira:LATE-STAGEHUNTINGTON'SDISEASE(HD):ACOHORTFROMTHEEUROPEANHDNETWORK.JournalofNeurology
Neurosurgery&Psychiatry09/2010;81(Suppl1):A24-A24.DOI:10.1136/jnnp.2010.222620.6
87. MiguelCoelho,MariaJMarti,EduardoTolosa,JoaquimJFerreira,FrancescValldeoriola,MárioRosa,CristinaSampaio:Late-stageParkinson's
disease:TheBarcelonaandLisboncohort.JournalofNeurology09/2010;257(9):1524-32.DOI:10.1007/s00415-010-5566-8
88. MárioMiguelRosa,JoaquimJFerreira,MiguelCoelho,RitaFreire,CristinaSampaio:PrescribingPatternsofAntiparkinsonianAgentsinEurope.
MovementDisorders06/2010;25(8):1053-60.DOI:10.1002/mds.23038
89. MScElanD.LouisMD,JoaquimJ.FerreiraMD,ElanD.Louis,JoaquimJ.Ferreira:HowCommonIstheMostCommonAdultMovementDisorder?
UpdateontheWorldwidePrevalenceofEssentialTremor.MovementDisorders04/2010;25(5):534-541.DOI:10.1002/mds.22838
90. TiagoMestre,JoaquimJFerreira:PharmacotherapyinParkinsongsdisease:Casestudies.TherapeuticAdvancesinNeurologicalDisorders03/2010;
3(2):117-26.DOI:10.1177/1756285609352366
91. RodrigoASalinas,GonzaloAlvarez,FergusDaly,JoaquimFerreira:CorticosteroidsforBell'spalsy(idiopathicfacialparalysis).Cochranedatabaseof
systematicreviews(Online)03/2010;3(3):CD001942.DOI:10.1002/14651858.CD001942.pub4
92. CristinaSampaio,JoaquimJFerreira:Parkinsondisease:ADAGIOtrialhintsthatrasagilineslowsdiseaseprogression.NatureReviewsNeurology
03/2010;6(3):126-8.DOI:10.1038/nrneurol.2010.2
93. PhDJoaquimJ.FerreiraMD,DulceNeutelMD,TiagoMestreMD,MiguelCoelhoMD,MárioM.RosaMD,PhDOlivierRascolMD,PhDCristina
SampaioMD:SkinCancerandParkinson'sDisease.MovementDisorders01/2010;25(2):139-148.DOI:10.1002/mds.22855
94. L.Negre-Pages,S.PerezLloret,P.Damier,A.Destee,F.Tison,C.Sampaio,J.Ferreira,P.MartinezMartin,O.Rascol:P3.135PredictivefactorsforPD
progression–preliminaryresultsofPARKMIP/COPARKcohortafter24-monthsfollowup.Parkinsonism&RelatedDisorders12/2009;15.
DOI:10.1016/S1353-8020(09)70699-6
95. T.F.Outeiro,JoaquimFerreira:CurrentandFutureTherapeuticStrategiesforParkinsonsDisease.Currentpharmaceuticaldesign12/2009;15(3434):3968-76.DOI:10.2174/138161209789649321
96. L.CorreiaGuedes,J.J.Ferreira,M.M.Rosa,MCoelho,VBonifati,CSampaio:WorldwidefrequencyofG2019SLRRK2mutationinParkinson'sdisease:
Asystematicreview.Parkinsonism&RelatedDisorders11/2009;16(4):237-42.DOI:10.1016/j.parkreldis.2009.11.004
97. HendaForeid,MiguelCoelho,JoaquimFerreira,JoséMFerro:Reversibleiatrogenicsubacutecerebellarsyndrome,myoclonusandMRIfindings
followingmetronidazoleadministration.CaseReports08/2009;2009.DOI:10.1136/bcr.05.2009.1841
98. AlessioDiFonzo,EditoFabrizio,AstridThomas,EmilianaFincati,RobertoMarconi,MicheleTinazzi,GuidoJBreedveld,ErikJSimons,HsinFChien,
JoaquimJFerreira,MartinWHorstink,GiovanniAbbruzzese,BarbaraBorroni,GiovanniCossu,AlessioDallaLibera,GiovanniFabbrini,MarcoGuidi,
MicheleDeMari,LeonardoLopiano,EmiliaMartignoni,PaoloMarini,MarcoOnofrj,AlessandroPadovani,FabrizioStocchi,VincenzoToni,Cristina
Sampaio,EgbertoRBarbosa,GiuseppeMeco,BenAOostra,VincenzoBonifati:GIGYF2mutationsarenotafrequentcauseoffamilialParkinson's
disease.Parkinsonism&RelatedDisorders06/2009;15(9):703-5.DOI:10.1016/j.parkreldis.2009.05.001
99. LilianaOlimGouveia,PedroCastanho,JoaquimJFerreira:SafetyofChiropracticInterventions.Spine06/2009;34(11):E405-13.
DOI:10.1097/BRS.0b013e3181a16d63
100. ElisaVedes,MiguelCoelho,JoaquimJ.Ferreira:P0394RETRO-ORBITALGRANULOMAASAMANIFESTATIONOFWEGENER'SGRANULOMATOSIS.
EuropeanJournalofInternalMedicine05/2009;20.DOI:10.1016/S0953-6205(09)60414-3
101. TiagoMestre,JoaquimJFerreira,SamayJain:AMultimodalApproachtoPhysicalTherapyinParkinson'sDisease:OptimizingStrategies.Movement
Disorders04/2009;24(6):946.DOI:10.1002/mds.22478
102. TiagoMestre,JoaquimJ.Ferreira:Eslicarbazepineacetate:Anewoptionforthetreatmentoffocalepilepsy.ExpertOpiniononInvestigationalDrugs
03/2009;18(2):221-9.DOI:10.1517/13543780802635107
103. TiagoMestre,JoaquimFerreira,JoséPimentel:Putaminalpetechialhaemorrhageasthecauseofnon-ketotichyperglycaemicchorea:A
neuropathologicalcasecorrelatedwithMRIfindings.CaseReports02/2009;2009.DOI:10.1136/bcr.08.2008.0785
104. TiagoMestre,JoaquimFerreira,MiguelMCoelho,MárioRosa,CristinaSampaio:Therapeuticinterventionsforsymptomatictreatmentin
Huntington'sdisease.Cochranedatabaseofsystematicreviews(Online)02/2009;3(3):CD006456.DOI:10.1002/14651858.CD006456.pub2
105. TiagoMestre,JoaquimFerreira,MiguelMCoelho,MárioRosa,CristinaSampaio:TherapeuticinterventionsfordiseaseprogressioninHuntington's
disease.Cochranedatabaseofsystematicreviews(Online)02/2009;3(3):CD006455.DOI:10.1002/14651858.CD006455.pub2
106. RodrigoASalinas,GonzaloAlvarez,JoaquimFerreira:WITHDRAWN:CorticosteroidsforBell'spalsy(idiopathicfacialparalysis).Cochranedatabaseof
systematicreviews(Online)02/2009;DOI:10.1002/14651858.CD001942.pub3
107. M.Coelho,A.F.Valadas,T.Mestre,J.J.Ferreira:Painandqualityoflifeinthetreatmentofcervicaldystonia.EuropeanNeurologicalReview01/2009;
4(2):74-78.DOI:10.17925/ENR.2009.04.02.74
108. OwenARoss,CleantheSpanaki,AlidaGriffith,Chin-HsienLin,JenniferKachergus,KristofferHaugarvoll,HelenLatsoudis,AndreasPlaitakis,JoaquimJ
Ferreira,CristinaSampaio,VincenzoBonifati,Ruey-MeeiWu,CyrusPZabetian,MatthewJFarrer:HaplotypeanalysisofLRRK2R1441Hcarrierswith
Parkinsonism.Parkinsonism&RelatedDisorders11/2008;15(6):466-7.DOI:10.1016/j.parkreldis.2008.09.001
109. LSilveira-Moriyama,LCGuedes,AKingsbury,HAyling,KShaw,ERBarbosa,VBonifati,NPQuinn,PAbou-Sleiman,NWWood,APetrie,CSampaio,J
JFerreira,JHolton,TRevesz,AJLees:HyposmiainG2019SLRRK2-relatedparkinsonism-Clinicalandpathologicdata.Neurology09/2008;
71(13):1021-6.DOI:10.1212/01.wnl.0000326575.20829.45
110. DanielGHealy,MarioFalchi,SeanSO'Sullivan,VincenzoBonifati,AlexandraDurr,SusanBressman,AlexisBrice,JanAasly,CyrusPZabetian,Stefano
Goldwurm,JoaquimJFerreira,EduardoTolosa,DeniseMKay,ChristineKlein,DavidRWilliams,ConnieMarras,AnthonyELang,ZbigniewKWszolek,
JoseBerciano,AnthonyHVSchapira,TimothyLynch,KailashPBhatia,ThomasGasser,AndrewJLees,NicholasWWood:InternationalLRRK2
Consortium.Phenotype,genotype,andworldwidegeneticpenetranceofLRRK2-associatedParkinson'sdisease:acase-controlstudy.TheLancet
Neurology08/2008;7(7):583-90.DOI:10.1016/S1474-4422(08)70117-0
111. MoorePeter,FerreiraJoaquim,PappertEric:A2-yearopen-labelstudyofbotulinumtoxintypeBinbotulinumtoxintypeAresistant/responsive
cervicaldystoniapatients(AN072-401EUICD).Toxicon06/2008;51:32-32.DOI:10.1016/j.toxicon.2008.04.097
112. PappertEric,GermansonTerry,MooreA.Peter,FerreiraJoaquim:BotulinumtoxintypeA(Botox)versusbotulinumtoxintypeB(Myobloc)insubjects
withcervicaldystonia:Acomparisonofthefrequencyofxerostomiaanddysphagia(AN072-402EU/CD).Toxicon06/2008;51:33-33.
DOI:10.1016/j.toxicon.2008.04.100
113. MoorePeter,FerreiraJoaquim,GermansonTerry,PappertEric:IstreatmentofcervicaldystoniapatientswithbotulinumtoxintypeBaffectedbya
previousresponsetoabotulinumtoxintypeA?Analysisofalong-termopen-labelstudy(AN072-401EU/CD).Toxicon06/2008;51:32-32.
DOI:10.1016/j.toxicon.2008.04.098
114. FerreiraJoaquim,MoorePeter,PappertEric:TheeffectsofrepeateddosingofbotulinumtoxintypeB(neurobloc(R))inpatientswithcervicaldystonia
previouslynaivetobotulinumtoxin:Anopen-labelextensionstudy(AN072-402EU/CD).Toxicon06/2008;51:40-40.
DOI:10.1016/j.toxicon.2008.04.120
115. RicardoFernandes,JoaquimJFerreira,CristinaSampaio:ThePlaceboResponseinStudiesofAcuteMigraine.TheJournalofpediatrics05/2008;
152(4):527-33,533.e1.DOI:10.1016/j.jpeds.2007.09.024
116. RLStowe,NJIves,CarlEClarke,JvanHilten,JoaquimFerreira,RobertJHawker,LailaShah,KeithWheatley,RichardGray:Dopamineagonisttherapy
inearlyParkinson'sdisease.Cochranedatabaseofsystematicreviews(Online)04/2008;2(2):CD006564.DOI:10.1002/14651858.CD006564.pub2
117. JoãoCosta,MariaLuzRocha,JoaquimFerreira,TeresinhaEvangelista,MiguelCoelho,MamededeCarvalho:Botulinumtoxintype-Bimproves
sialorrheaandqualityoflifeinbulbaronsetamyotrophiclateralsclerosis.JournalofNeurology04/2008;255(4):545-50.DOI:10.1007/s00415-0080738-5
118. MiguelCoelho,JoaquimFerreira,MárioRosa,CristinaSampaio:Treatmentoptionsfornon-motorsymptomsinlate-stageParkinson'sdisease.Expert
OpiniononPharmacotherapy04/2008;9(4):523-35.DOI:10.1517/14656566.9.4.523
119. JoaquimJFerreira,LuisAlmeida,LuisCunha,MarinaTicmeanu,MárioMRosa,CristinaJanuário,Cristina-ElenaMitu,MiguelCoelho,LeonorCorreiaGuedes,AnaMorgadinho,TeresaNunes,LyndonCWright,AmílcarFalcão,CristinaSampaio,PatrícioSoares-da-Silva:EffectsofNebicaponeon
LevodopaPharmacokinetics,Catechol-O-methyltransferaseActivity,andMotorFluctuationsinPatientswithParkinsonDisease.Clinical
neuropharmacology01/2008;31(1):2-18.DOI:10.1097/wnf.0b013e3180645cb0
120. LilianaOlimGouveia,PedroCastanho,JoaquimJFerreira,MiguelMouraGuedes,FilipaFalcão,TeresaPinhoeMelo:Chiropracticmanipulation:
Reasonsforconcern?.ClinicalNeurologyandNeurosurgery01/2008;109(10):922-5.DOI:10.1016/j.clineuro.2007.08.004
121. L.Almeida,J.Ferreira,T.Nunes,R.Machado,L.Torrão,J.Costa,E.Soares,J.Rocha,A.Falcão,L.Wright,P.SoaresdaSilva:Effectofnebicapone(BIA
3-202)onthepharmacokineticsoflevodopaandcatechol-O-methyltransferase(COMT)activityinpatientswithParkinson’sdisease.BritishJournalof
ClinicalPharmacology12/2007;63(6):784-785.
122. ACFonseca,JJFerreira,LAlbuquerque,JMFerro:Sneezeasaprecipitatingfactorofcerebralvenousthrombosis.EuropeanJournalofNeurology
11/2007;14(10):e7-8.DOI:10.1111/j.1468-1331.2007.01914.x
123. M.Atadzhanov,P.Mwaba,MamededeCarvalho,JoaoCosta,JoaquimFerreira:Upperlimbtremorinducedbyperipheralnerveinjury-Reply.
Neurology09/2007;69(13):1381-1381.DOI:10.1212/01.wnl.0000286557.14108.1c
124. JoaquimFerreira,JoãoMaiaSilva,RitaFreire,JoãoPignatelli,LeonorCorreiaGuedes,AlexandraFeijó,MárioMiguelRosa,MiguelCoelho,JoãoCosta,
AnaNoronha,RussellHewett,AMarquesGomes,J.L.CirnedeCastro,OlivierRascol,CristinaSampaio:Skincancersandprecancerouslesionsin
Parkinson'sdiseasepatients.MovementDisorders07/2007;22(10):1471-5.DOI:10.1002/mds.21575
125. JoaquimJFerreira,LeonorCorreiaGuedes,MárioMiguelRosa,MiguelCoelho,MarinavanDoeselaar,DorotheaSchweiger,AlessioDiFonzo,BenA
Oostra,CristinaSampaio,VincenzoBonifati:HighprevalenceofLRRK2mutationsinfamilialandsporadicParkinson'sdiseaseinPortugal.Movement
Disorders06/2007;22(8):1194-201.DOI:10.1002/mds.21525
126. TiagoAMestre,JoaquimJFerreira,JoséPimentel:Putaminalpetechialhaemorrhageasthecauseofnon-ketotichyperglycaemicchorea:A
neuropathologicalcasecorrelatedwithMRIfindings[7].Journalofneurology,neurosurgery,andpsychiatry06/2007;78(5):549-50.
DOI:10.1136/jnnp.2006.105387
127. ADiFonzo,H.F.Chien,SocalMM,GiraudoSB,TassorelliCM,IlicetoGM,FabbriniGM,MarconiRM,FincatiEM,AbbruzzeseGM,PMarini,FSquitieri,
M.W.Horstink,PMontagna,ADallaLibera,FStocchi,SGoldwurm,J.J.Ferreira,GMeco,EMartignoni,LLopiano,L.B.Jardim,B.A.Oostra,E.R.
Barbosa,VBonifati:DiFonzo,A.etal.ATP13A2missensemutationsinjuvenileparkinsonismandyoungonsetParkinsondisease.Neurology68,15571562.Neurology05/2007;68(19):1557-62.DOI:10.1212/01.wnl.0000260963.08711.08
128. JoaquimJFerreira,JoãoCosta,MiguelCoelho,CristinaSampaio:Themanagementofcervicaldystonia.ExpertOpiniononPharmacotherapy03/2007;
8(2):129-40.DOI:10.1517/14656566.8.2.129
129. JoaquimJosFerreira,CristinaSampaio:Essentialtremor..Clinicalevidence02/2007;2007.
130. ChristopherGGoetz,ChristineHicking,EugeneLaska,ThomasMüller,CWarrenOlanow,HermannRuss,Bajaj,R.Barker,O.Blin,D.Burn,N.
Carciumaru,A.Ceballos-Baumann,D.Constantin,A.Csanyi,L.Cunha,PhilippeDamier,R.Dom,F.Durif,H.Fernandez,J.J.Ferreira,J.Fine,G.Gacs,D.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
L.Giampaolo,R.Grunewald,P.Harcos,S.Horn,J.Jankovic,W.H.Jost,W.C.Koller,D.M.Lurie,W.R.W.Martin,I.G.Milanov,A.Moser,T.Müller,R.
Pahwa,I.Pascu,R.Pfeiffer,OlivierRascol,H.Reichmann,I.Sagi,A.Sahay,M.Saint-Hillaire,J.Schwarz,A.Serbanescu,K.D.Sethi,P.M.Shotekov,C.
Singer,J.Smuts,P.Stamenova,A.Storch,J.W.Tetrud,J.Thorne,D.D.Truong,J.Tsui,S.I.Veleva,L.Verhagen,R.L.Watts,D.Woitalla,T.Zesiewicz:
SarizotanasatreatmentfordyskinesiasinParkinson'sdisease:Adouble-blindplacebo-controlledtrial.MovementDisorders02/2007;22(2):179-86.
DOI:10.1002/mds.21226
JCosta,RHenriques,CBarroso,JFerreira,AAtalaia,MdeCarvalho:Upperlimbtremorinducedbyperipheralnerveinjury.Neurology12/2006;
67(10):1884-6.DOI:10.1212/01.wnl.0000244437.31413.2b
AlessioDiFonzo,CristinaTassorelli,MicheleDeMari,HsinFChien,JoaquimFerreira,ChristanFRohé,GiulioRiboldazzi,AngeloAntonini,Gianni
Albani,AlessandroMauro,RobertoMarconi,GiovanniAbbruzzese,LeonardoLopiano,EmilianaFincati,MarcoGuidi,PaoloMarini,FabrizioStocchi,
MarcoOnofrj,VincenzoToni,MicheleTinazzi,GiovanniFabbrini,PaoloLamberti,NicolaVanacore,GiuseppeMeco,PetraLeitner,RyanJUitti,
ZbigniewKWszolek,ThomasGasser,ErikJSimons,GuidoJBreedveld,StefanoGoldwurm,GianniPezzoli,CristinaSampaio,EgbertoBarbosa,Emilia
Martignoni,BenAOostra,VincenzoBonifati:ComprehensiveanalysisoftheLRRK2geneinsixtyfamilieswithParkinson'sdisease.EuropeanJournalof
HumanGenetics04/2006;14(3):322-31.DOI:10.1038/sj.ejhg.5201539
JJFerreira,KDesboeuf,MGalitzky,CThalamas,CBrefel-Courbon,NFabre,J-MSenard,J-LMontastruc,CSampaio,ORascol:Sleepdisruption,
daytimesomnolenceand'sleepattacks'inParkinson'sdisease:AclinicalsurveyinPDpatientsandage-matchedhealthyvolunteers.EuropeanJournal
ofNeurology04/2006;13(3):209-14.DOI:10.1111/j.1468-1331.2006.01262.x
YlmarCorrêaNeto,FranciscoCardoso,AntonioLúcioTeixeira,DéboraPalmaMaia,RogérioBeato,JoaquimFerreira:[ThechoreaofZezé]..Acta
medicaportuguesa03/2006;19(2):127-32.
FGeser,KSeppi,MStampfer-Kountchev,MKöllensperger,ADiem,JPNdayisaba,KOstergaard,EDupont,ACardozo,ETolosa,MAbele,RDodel,T
Klockgether,IGhorayeb,FYekhlef,FTison,CDaniels,FKopper,GDeuschl,MCoelho,JFerreira,MMRosa,CSampaio,MBozi,ASchrag,JHooker,H
Kim,TScaravilli,CJMathias,CFowler,NWood,NQuinn,HWidner,CFNilsson,OLindvall,NSchimke,KMEggert,WOertel,FdelSorbo,FCarella,A
Albanese,MTPellecchia,PBarone,RDjaldetti,GMeco,CColosimo,AGonzalez-Mandly,JBerciano,TGurevich,NGiladi,MGalitzky,FOry,ORascol,
CKamm,KBuerk,SMaass,TGasser,WPoewe,GKWenning:TheEuropeanMultipleSystemAtrophy-StudyGroup(EMSA-SG).JournalofNeural
Transmission01/2006;112(12):1677-86.DOI:10.1007/s00702-005-0328-y
JoaquimJFerreira,MarinaCouto,JoãoCosta,MiguelCoelho,MárioMRosa,CristinaSampaio:[Botulinumtoxinforthetreatmentofpain
syndromes]..Actareumatologicaportuguesa01/2006;31(1):49-62.
SGoldwurm,ADiFonzo,EJSimons,CFRohé,MZini,MCanesi,STesei,AZecchinelli,AAntonini,CMariani,NMeucci,GSacilotto,FSironi,GSalani,J
Ferreira,HFChien,EFabrizio,NVanacore,ADallaLibera,FStocchi,CDiroma,PLamberti,CSampaio,GMeco,EBarbosa,AMBertoli-Avella,GJ
Breedveld,BAOostra,GPezzoli,VBonifati:TheG6055A(G2019S)mutationinLRRK2isfrequentinbothearlyandlateonsetParkinson'sdiseaseand
originatesfromacommonancestor.JournalofMedicalGenetics11/2005;42(11):e65.DOI:10.1136/jmg.2005.035568
J.Costa,C.Espírito-Santo,A.Borges,J.J.Ferreira,M.Coelho,PMoore,C.Sampaio:BotulinumtoxinTypAversusAnticholinergikazurBehandlungder
zervikalenDystonie.Praxis09/2005;94(36):1393-1393.DOI:10.1024/0369-8394.94.36.1393
J.Costa,C.Espírito-Santo,A.Borges,J.J.Ferreira,M.Coelho,PMoore,C.Sampaio:BotulinumtoxinTypAzurBehandlungdesSpasmushemifacialis.
Praxis09/2005;94(36):1394-1394.DOI:10.1024/0369-8394.94.36.1394
J.Costa,C.Espírito-Santo,A.Borges,J.J.Ferreira,M.Coelho,P.Moore,C.Sampaio:BotulinumtoxinTypBzurBehandlungderzervikalenDystonie.
Praxis08/2005;94(35):1349-1350.DOI:10.1024/0369-8394.94.35.1349
JoãoCosta,CláudiaCEspírito-Santo,AnaABorges,JJFerreira,MiguelMCoelho,PeterMoore,CristinaSampaio:BotulinumtoxintypeAtherapyfor
blepharospasm.Cochranedatabaseofsystematicreviews(Online)02/2005;1(1):CD004900.DOI:10.1002/14651858.CD004900.pub2
JoãoCosta,CláudiaCEspírito-Santo,AnaABorges,JJFerreira,MiguelMCoelho,PeterMoore,CristinaSampaio:BotulinumtoxintypeAtherapyfor
hemifacialspasm.Cochranedatabaseofsystematicreviews(Online)02/2005;DOI:10.1002/14651858.CD004899.pub2
JoãoCosta,CláudiaCEspírito-Santo,AnaABorges,JJFerreira,MiguelMCoelho,PeterMoore,CristinaSampaio:BotulinumtoxintypeBforcervical
dystonia.Cochranedatabaseofsystematicreviews(Online)02/2005;1(1):CD004315.DOI:10.1002/14651858.CD004315.pub2
JoãoCosta,AnaABorges,CláudiaCEspírito-Santo,JoaquimFerreira,MiguelMCoelho,PeterMoore,CristinaSampaio:BotulinumtoxintypeBfor
cervicaldystonia.Cochranedatabaseofsystematicreviews(Online)02/2005;1(1):CD004314.DOI:10.1002/14651858.CD004314.pub2
JCosta,CEspírito-Santo,ABorges,JJFerreira,MCoelho,CSampaio:BotulinumtoxintypeAversusanticholinergicsforcervicaldystonia.Cochrane
databaseofsystematicreviews(Online)02/2005;1(1):CD004312.DOI:10.1002/14651858.CD004312.pub2
JoãoCosta,CláudiaCEspírito-Santo,AnaABorges,J.J.Ferreira,MiguelMCoelho,PeterMoore,CristinaSampaio:BotulinumtoxintypeAtherapyfor
cervicaldystonia.Cochranedatabaseofsystematicreviews(Online)02/2005;1(1):CD003633.DOI:10.1002/14651858.CD003633.pub2
ADifonzo,C.F.Rohé,JFerreira,H.F.Chien,LVacca,FStocchi,LGuedes,EFabrizio,MManfredi,NVanacore:AfrequentLRRK2genemutation
associatedwithautosomaldominantParkinson’sdisease.TheLancet01/2005;365(9457):412-415.DOI:10.1016/S0140-6736(05)70236-1
AlessioDiFonzo,ChristanFRohé,JoaquimFerreira,HsinFChien,LauraVacca,FabrizioStocchi,LeonorGuedes,EditoFabrizio,MarioManfredi,
NicolaVanacore,StefanoGoldwurm,GuidoBreedveld,CristinaSampaio,GiuseppeMeco,EgbertoBarbosa,BenAOostra,VincenzoBonifati:Di
Fonzo,A.etal.AfrequentLRRK2genemutationassociatedwithautosomaldominantParkinson'sdisease.Lancet365,412-415.TheLancet01/2005;
365(9457):412-5.DOI:10.1016/S0140-6736(05)17829-5
MiguelCoelho,JoaquimJoséFerreira,BeatrizDias,CristinaSampaio,IsabelPavãoMartins,AlexandreCastro-Caldas:Assessmentoftimeperception:
Theeffectofaging.JournaloftheInternationalNeuropsychologicalSociety06/2004;10(3):332-41.DOI:10.1017/S1355617704103019
CristinaSampaio,JoãoCosta,JoaquimJFerreira:Clinicalcomparabilityofmarketedformulationsofbotulinumtoxin.MovementDisorders04/2004;
19Suppl8(19suppl8):S129-36.DOI:10.1002/mds.20066
RASalinas,GonzaloAlvarez,JoaquimFerreira:CorticosteroidsforBell'spalsy(idiopathicfacialparalysis)(CochraneReview).Cochranedatabaseof
systematicreviews(Online)02/2004;4(4):CD001942.DOI:10.1002/14651858.CD001942.pub2
OlivierRascol,CBrefel-Courbon,PPayoux,JFerreira:ThemanagementofpatientswithearlyParkinson'sdisease..Advancesinneurology02/2003;
91:203-11.
ORascol,JJFerreira,PPayoux,ChBrefel-Courbon,JLMontastruc:Managementoflevodopa-induceddyskinesia.RevueNeurologique01/2003;158
Specno1(122):S117-24.
OlivierRascol,PierrePayoux,FabienneOry,JoaquimJFerreira,ChristineBrefel-Courbon,Jean-LouisMontastruc:LimitationsofcurrentParkinson's
diseasetherapy.AnnalsofNeurology01/2003;53Suppl3(S3):S3-12;discussionS12-5.DOI:10.1002/ana.10513
R.A.Salinas,G.Alvarez,M.I.Alvarez,J.Ferreira:KortikosteroidezurBehandlungderidiopathischenFazialisparese(Bell'scheParese).Praxis12/2002;
91(51):2255-2255.DOI:10.1024/0369-8394.91.51.2255
156. ORascol,PPayoux,JFerreira,CBrefel-Courbon:ThemanagementofpatientswithearlyParkinson'sdisease.Parkinsonism&RelatedDisorders
11/2002;9(1):61-7.DOI:10.1016/S1353-8020(02)00045-7
157. CristinaSampaio,JoaquimJFerreira,JoãoCosta:Evidence-basedmedicine(EBM)appliedtoParkinson'sdiseasetreatment.Parkinsonism&Related
Disorders11/2002;9(1):7-13.DOI:10.1016/S1353-8020(02)00039-1
158. YoshioTsuboi,RyanJUitti,Marie-BernadetteDelisle,JoaquimJFerreira,ChristineBrefel-Courbon,OlivierRascol,BernardinoGhetti,JillRMurrell,
MichaelHutton,MatthewBaker,ZbigniewKWszolek:ClinicalfeaturesanddiseasehaplotypesofindividualswiththeN279Ktaugenemutation-A
comparisonofthepallidopontonigraldegenerationkindredandaFrenchfamily.JAMANeurology07/2002;59(6):943-50.
DOI:10.1001/archneur.59.6.943
159. CristinaSampaio,JoaquimFerreira:Essentialtremor.Clinicalevidence07/2002;12(7):1169-78.
160. JJFerreira,MGalitzky,CThalamas,MTiberge,JLMontastruc,CSampaio,ORascol:Effectofropiniroleonsleeponset:Arandomized,placebocontrolledstudyinhealthyvolunteers.Neurology03/2002;58(3):460-2.DOI:10.1212/WNL.58.3.460
161. RASalinas,GAlvarez,MIAlvarez,JFerreira:CorticosteroidsforBell’sPalsy(idiopathicfacialparalysis).Cochranedatabaseofsystematicreviews
(Online)02/2002;1(1):CD001942.DOI:10.1002/14651858.CD001942
162. JCosta,EIdeOliveira,MMRosa,JJFerreira,CSampaio,AVCarneiro:[Cardiaceffectsofacutepoisoningwithtricyclicantidepressants:systematic
reviewoftheliterature--PartIV]..Revistaportuguesadecardiologia:orgaooficialdaSociedadePortuguesadeCardiologia=Portuguesejournalof
cardiology:anofficialjournalofthePortugueseSocietyofCardiology11/2001;20(10):1021-30.
163. ORascol,JFerreira,JLMontastruc:[Abnormaldiurnalsomnolence,"sleepattacks"andantiparkinsondrugs]..RevueNeurologique11/2001;
157(10):1313-23.
164. JCosta,EIdeOliveira,MMRosa,JJFerreira,CSampaio,AVCarneiro:[Cardiaceffectsofacutepoisoningwithtricyclicantidepressants:systematic
reviewoftheliterature--PartIII]..Revistaportuguesadecardiologia:orgaooficialdaSociedadePortuguesadeCardiologia=Portuguesejournalof
cardiology:anofficialjournalofthePortugueseSocietyofCardiology10/2001;20(9):901-9.
165. JCosta,MMRosa,JJFerreira,CSampaio,AVazCarneiro:[Cardiaceffectsofacutepoisoningwithtricyclicantidepressants:systematicreviewofthe
literature.PartI]..Revistaportuguesadecardiologia:orgaooficialdaSociedadePortuguesadeCardiologia=Portuguesejournalofcardiology:an
officialjournalofthePortugueseSocietyofCardiology07/2001;20(6):671-8.
166. J.L.Montastruc,ChristineBrefel-Courbon,J.M.Senard,HalehBagheri,JoaquimFerreira,OlivierRascol,MaryseLapeyre-Mestre:SleepAttacksand
AntiparkinsonianDrugs:APilotProspectivePharmacoepidemiologicStudy.ClinicalNeuropharmacology05/2001;24(3):181-3.
DOI:10.1097/00002826-200105000-00013
167. Jean-LouisMontastruc,ChristineBrefel-Courbon,Jean-MichelSenard,HalehBagheri,JoaquimFerreira,OlivierRascol,MaryseLapeyre-Mestre:Sleep
AttacksandAntiparkinsonianDrugs:APilotProspectivePharmacoepidemiologicStudy.ClinicalNeuropharmacology04/2001;24(3):181-183.
168. JoaquimJ.Ferreira,ClaireThalamas,JeanLouisMontastruc,AlexandreCastro-Caldas,OlivierRascol:Levodopamonotherapycaninduce“sleep
attacks”inParkinson'sdiseasepatients.JournalofNeurology04/2001;248(5):426-427.DOI:10.1007/s004150170188
169. ORascol,JJFerreira,CThalamas,MGalitsky,JLMontastruc:Dopamineagonists.TheirroleinthemanagementofParkinson'sdisease..Advancesin
neurology02/2001;86:301-9.
170. CSampaio,JFerreira,JCosta:[Numbersneededfortreatmentandtheirrespectiveconfidenceintervals:usefultoolstoassessclinicalsignificanceand
uncertaintyassociatedwithmedicalinterventions]..Revistaportuguesadecardiologia:orgaooficialdaSociedadePortuguesadeCardiologia=
Portuguesejournalofcardiology:anofficialjournalofthePortugueseSocietyofCardiology01/2001;19(12):1303-8.
171. TWarner,LCamfield,CDMarsden,AHNemeth,NHyman,DHarley,JWissel,WPoewe,RJMarttila,HErjanti,PBurbaud,ALagueny,CKamm,T
Gasser,DFranz,ECastelon-Konkiewitz,ITrender,ACeballos-Baumann,ANebe,BFreudenberg,ABentivoglio,ECassetta,AAlbanese,ACurra,L
Vacca,ABerardelli,JFerreira,CSampaio,VPassao,FMarti,ETolosa,LClaveria,JDuarte,YBen-Shlomo,ANewton:Aprevalencestudyofprimary
dystoniaineightEuropeancountries.JournalofNeurology10/2000;247(10):787-792.
172. JoaquimJ.Ferreira,OlivierRascol:Preventionandtherapeuticstrategiesforlevodopa-induceddyskinesiasinParkinson'sdisease.CurrentOpinionin
Neurology09/2000;13(4):431-6.DOI:10.1097/00019052-200008000-00011
173. JFerreira,MGalitzky,JLMontastruc,ORascol:SleepattacksinParkinson'sdisease-Reply.TheLancet08/2000;356(9229):598.DOI:10.1016/S01406736(05)73982-9
174. JJFerreira,MGalitzky,JLMontastruc,ORascol:SleepattacksandParkinson'sdiseasetreatment.TheLancet05/2000;355(9212):1333-4.
DOI:10.1016/S0140-6736(00)02119-X
175. JMFerro,ANPinto,IFalcão,GRodrigues,JFerreira,FFalcão,EAzevedo,PCanhão,TPMelo,MJRosas,VOliveira,AVSalgado:DiagnosisofStroke
bytheNonneurologist:AValidationStudy.Stroke07/1998;29(6):1106-9.DOI:10.1161/01.STR.29.6.1106
176. CristinaSampaio,JoaquimJ.Ferreira,FernandaSimões,MariaJ.Rosas,MarinaMagalhães,AnaP.Correia,AntónioBastos-Lima,RairnundoMartins,
AlexandreCastro-Caldas:DYSBOT:Asingle-blind,randomizedparallelstudytodeterminewhetheranydifferencescanbedetectedintheefficacyand
tolerabilityoftwoformulationsofBotulinumToxinTypeA-DysportandBotox-assumingaratioof4:1.MovementDisorders11/1997;12(6):1013-8.
DOI:10.1002/mds.870120627
177. CristinaSampaio,JoaquimJFerreira,AnaAPinto,CrespoMC,JoséMFerro,AlexandreCastro-Caldas:BotulinumtoxintypeAforthetreatmentofarm
andhandspasticityinstrokepatients.Clin.Rehabil.11,3-7.ClinicalRehabilitation03/1997;11(1):3-7.DOI:10.1177/026921559701100102
178. J.J.Ferreira,J.F.Rocha,A.Santos,T.Nunes,P.Soares-Da-Silva:Thedesignofadouble-blind,placebo-andactive-controlled,multi-nationalphase-III
trialinpatientswithParkinson'sdiseaseandend-of-dosemotorfluctuations:Opicaponesuperiorityvs.Placeboandnon-inferiorityvs.Entacapone.
179. JJFerreira,CSampaio:[CriticalassessmentofarticlesoncontrolledclinicaltrialsII.Results]..Actamédicaportuguesa11(8-9):755-60.
180. CSampaio,JJFerreira:[Criticalassessmentofarticlesoncontrolledclinicaltrials.I.Planning]..Actamédicaportuguesa11(8-9):749-54.
181. CSampaio,JJFerreira:[Cochranecollaboration.Whatisit?Whatisitfor?Howdoesitcontributetothepracticeofevidencebasedmedicine?]..Acta
médicaportuguesa11(8-9):739-44.
182. JCosta,EIdeOliveira,MMRosa,JJFerreira,CSampaio,AVCarneiro:[Cardiaceffectsofacutepoisoningwithtricyclicantidepressants:systematic
reviewoftheliterature--PartII]..Revistaportuguesadecardiologia:orgaooficialdaSociedadePortuguesadeCardiologia=Portuguesejournalof
cardiology:anofficialjournalofthePortugueseSocietyofCardiology20(7-8):765-72.